Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Title Grant Type Focus Area Country Application Due Date Improving the Care of Persons Living with Metastatic Breast CancerRelease Date:Partner: Rethink Breast CancerQuality Improvement Oncology Canada Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditionsRelease Date:Education Inflammation & Immunology Canada Improving Advanced Prostate Cancer Management in Latin AmericaEducation Oncology Argentina, Brazil, Chile, Colombia, Mexico Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient CareResearch Oncology USA Addressing Knowledge Gaps in Ulcerative Colitis (UC) CareRelease Date:Education Inflammation & Immunology USA 2024 Inflammatory Bowel Disease (IBD) Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Closing the HRRm Testing Gap in Prostate Cancer PatientsRelease Date:Quality Improvement Oncology Canada Improving the care and outcomes of residents of Canada living with metastatic NSCLCRelease Date:Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung AssociationQuality Improvement Oncology Canada Improving the Equity and Quality of Cancer Care in ColombiaRelease Date:Partner: The Colombian Association of Oncology and Hematology (ACHO)Quality Improvement Oncology Colombia Enhancing Molecular Testing for Metastatic Colorectal Cancer PatientsRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement Oncology Canada Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial InfectionsRelease Date:Education Hospital All IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)Release Date:Partner: Crohn's & Colitis FoundationQuality Improvement Inflammation & Immunology USA